Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

Dr. Sulaiman Al Habib stock at SAR 224.10, 20.3 percent below high

Published on 10/12/2026 at 13:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dr. Sulaiman Al Habib stock stood at SAR 224.10 on October 12, 2026. That is 20.3 percent below its SAR 281.20 high.

Key points in brief

Dr. Sulaiman Al Habib stock stood at SAR 224.10 on October 12, 2026.
The price was 20.30 percent below the SAR 281.20 52-week high.
Market capitalization was SAR 78.4 billion and the P/E ratio was 32.43.
H1 2026 net income reached SAR 1.166 billion, up 2.00 percent year over year.

Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

Dr. Sulaiman Al Habib Medical Services stock stood at SAR 224.10 on Tadawul on October 12, 2026, at 2:12 p.m. AST. The price was 20.30 percent below its 52-week high of SAR 281.20, putting the valuation and recent earnings growth side by side for investors.

Price stays below yearly high

The stock's 52-week range was SAR 210.10 to SAR 281.20 on October 12, 2026. At SAR 224.10, the price was 6.66 percent above the range low, while trading volume reached 33,379 shares against an average of 140,071 shares.

Market capitalization stood at SAR 78.4 billion on October 12, 2026. The trailing P/E ratio was 32.43 and the dividend yield was 2.00 percent, giving the price report a clear valuation anchor without turning the figures into a recommendation.

Recent earnings remain the counterweight

Argaam reported that net income reached SAR 1.166 billion in the first half of 2026, up 2.00 percent from the year-earlier period. Second-quarter net income was SAR 662.70 million, 12.00 percent above the first quarter's SAR 503.30 million.

The annual comparison is also substantial. Reuters lists 2025 revenue at SAR 13.7 billion and net income at SAR 2.4 billion, compared with SAR 11.2 billion and SAR 2.3 billion in 2024.

Comparison with peers on October 12, 2026

Dr. Sulaiman Al Habib Medical Services: P/E 32.43, market capitalization SAR 78.4 billion
Dallah Healthcare (Tadawul, SAR): minus 0.51 percent, P/E 17.84, market capitalization SAR 7.9 billion
Mouwasat Medical Services (Tadawul, SAR): minus 0.32 percent, P/E 14.40, market capitalization SAR 12.3 billion

Healthcare valuation in context

The comparison places Dr. Sulaiman Al Habib at a higher P/E than both named healthcare peers, while its market capitalization is also materially larger. Its earnings profile supplies the operating context: first-half net income was SAR 1.166 billion, and second-quarter profit exceeded first-quarter profit by SAR 159.40 million.

The company operates hospitals, medical complexes, pharmacies, laboratories, telemedicine services and other healthcare businesses across Saudi Arabia. Its business mix gives the stock a direct link to healthcare demand, while the valuation premium remains the central market statistic in this report.

Stock profile and price level

Dr. Sulaiman Al Habib Medical Services Group Company was trading at SAR 224.10 on Tadawul on October 12, 2026 at 2:12 p.m. AST. The 52-week high was SAR 281.20 and the 52-week low was SAR 210.10.